Label Value
DOI 10.1038/bjc.2016.419
TITLE Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-02-12T10:47:46.394755
Web of Science Yes 2018-04-08T07:26:48.417276
Compendex No 2019-12-19T06:17:34.260540